Medtronic told physicians at the American College of Cardiology meeting this week that sudden cardiac death in a specific subset of immediate post-MI patients was significantly reduced with implantable cardioverter-defibrillator (ICD) therapy.
Helps planning for targeted prostate cancer therapies.
Can measure the absorbed dose from MRT for individual patients
Dr. Ashok Joseph Theruvath, postdoctoral research fellow in the Molecular Imaging Program at the Stanford School of Medicine discusses promising research for assessing pediatric chemo outcomes
Shifting Territories: Trends in the Catheterization and Angiography Lab
The meeting will take place at the Bellagio Hotel in Las Vegas, Nev. from April 28 to May 2.
Involves multiparametric MR protocols
Doctors identify just six risk factors for brain damage after head trauma in children; could reduce number of kids exposed to cancer-causing CT radiation.
Can the CorPath GRX enable more patients to undergo PCI?
Microwave technology originally designed to shoot down nuclear missiles could help zap breast cancer tumors, according to a study in a recent issue of Annals of Surgical Oncology.
Enables specialists to intervene before notified by a radiologist
CT and MR images will be used to determine risk
Vows to continue pursuing coverage for Medicare patients
The LifeForce QMA Series Isokinetic Testing and Evaluation System is a tool that will confirm your diagnosis, document your patients' physical therapy and provide objective substantiation to your Functional Capacity Examinations.
There's also an Aquilion 64-slice CT scanner manufactured June 2007 up for bid... and check out all our hospital surplus equipment auctions... there's something for everyone!
National Institute of Biomedical Imaging and Bioengineering appoints director
Will develop technology to process high data volume that PCCT generates
Ensures patient safety and relaxation during MR exams
Post is for innovative therapy in pediatric cancer.
Could help predict how patients will respond to treatment
PET images of early-stage neuroblastoma can provide important information for certain patients.
From the October issue of HCB News magazine
By injecting man-made, microscopic tubes into tumors and heating them with a quick, 30-second zap of a laser, scientists have discovered a way to effectively kill kidney tumors in nearly 80 percent of mice. Researchers say the finding suggests a potentially exciting cancer treatment.
